对于具有焦点细分型淋巴结核硬化病变的异常性膜性脏病,可能需要积极的治疗

Ping Cheng1, Qionghong Xie1, Shaojun Liu1

  • 1Huashan Hospital Affiliated to Fudan University, Department of Nephrology - Shanghai, China.

Revista da Associacao Medica Brasileira (1992)
|May 8, 2024
PubMed
概括

具有焦点细分结核硬化 (FSGS) 病变的异常膜性病症呈现出更严重的病综合征和更差的功能. 建议对这些患者进行积极的免疫抑制治疗,以防止衰退.